344 related articles for article (PubMed ID: 20002080)
1. Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders.
Heal DJ; Gosden J; Smith SL
Br J Clin Pharmacol; 2009 Dec; 68(6):861-74. PubMed ID: 20002080
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
3. Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines.
Correia ML; Haynes WG
Expert Opin Emerg Drugs; 2005 Aug; 10(3):643-60. PubMed ID: 16083333
[TBL] [Abstract][Full Text] [Related]
4. Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles.
Krentz AJ; Fujioka K; Hompesch M
Diabetes Obes Metab; 2016 Jun; 18(6):558-70. PubMed ID: 26936802
[TBL] [Abstract][Full Text] [Related]
5. Rise in antiobesity drug prescribing for children and adolescents in the UK: a population-based study.
Viner RM; Hsia Y; Neubert A; Wong IC
Br J Clin Pharmacol; 2009 Dec; 68(6):844-51. PubMed ID: 20002078
[TBL] [Abstract][Full Text] [Related]
6. Is there a path for approval of an antiobesity drug: what did the Sibutramine Cardiovascular Outcomes Trial find?
Downey M; Still C; Sharma AM
Curr Opin Endocrinol Diabetes Obes; 2011 Oct; 18(5):321-7. PubMed ID: 21878755
[TBL] [Abstract][Full Text] [Related]
7. Updates on obesity pharmacotherapy.
Velazquez A; Apovian CM
Ann N Y Acad Sci; 2018 Jan; 1411(1):106-119. PubMed ID: 29377198
[TBL] [Abstract][Full Text] [Related]
8. New drug policy in childhood obesity.
Molnár D
Int J Obes (Lond); 2005 Sep; 29 Suppl 2():S62-5. PubMed ID: 16385755
[TBL] [Abstract][Full Text] [Related]
9. American Diabetes Association--69th Scientific sessions. Obesity management and treatment of type 2 diabetes: Part 1.
Kouremenou C
IDrugs; 2009 Aug; 12(8):463-4. PubMed ID: 19629873
[No Abstract] [Full Text] [Related]
10. Pharmacotherapy of obesity: currently marketed and upcoming agents.
Bays H; Dujovne C
Am J Cardiovasc Drugs; 2002; 2(4):245-53. PubMed ID: 14727970
[TBL] [Abstract][Full Text] [Related]
11. Emerging pharmacotherapy for treating obesity and associated cardiometabolic risk.
Caterson ID; Finer N
Asia Pac J Clin Nutr; 2006; 15 Suppl():55-62. PubMed ID: 16928662
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy for Patients with Obesity.
Gadde KM; Apolzan JW; Berthoud HR
Clin Chem; 2018 Jan; 64(1):118-129. PubMed ID: 29054924
[TBL] [Abstract][Full Text] [Related]
13. Obesity medications: what does the future look like?
Butsch WS
Curr Opin Endocrinol Diabetes Obes; 2015 Oct; 22(5):360-6. PubMed ID: 26313898
[TBL] [Abstract][Full Text] [Related]
14. Role of glucagon-like peptide 1 receptor agonists in management of obesity.
Isaacs D; Prasad-Reddy L; Srivastava SB
Am J Health Syst Pharm; 2016 Oct; 73(19):1493-507. PubMed ID: 27521241
[TBL] [Abstract][Full Text] [Related]
15. 11-Beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors in type 2 diabetes mellitus and obesity.
Hughes KA; Webster SP; Walker BR
Expert Opin Investig Drugs; 2008 Apr; 17(4):481-96. PubMed ID: 18363514
[TBL] [Abstract][Full Text] [Related]
16. Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome.
Maksimov ML; Svistunov AA; Tarasov VV; Chubarev VN; Ávila-Rodriguez M; Barreto GE; Dralova OV; Aliev G
Curr Pharm Des; 2016; 22(7):895-903. PubMed ID: 26648466
[TBL] [Abstract][Full Text] [Related]
17. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes.
Lau DC; Teoh H
Can J Diabetes; 2015 Dec; 39 Suppl 5():S134-41. PubMed ID: 26654857
[TBL] [Abstract][Full Text] [Related]
18. Metabolic diseases.
Balfe A; Perry L
IDrugs; 2006 Nov; 9(11):754-5. PubMed ID: 17096291
[No Abstract] [Full Text] [Related]
19. Pharmacotherapy for obesity in menopausal women.
Samat A; Rahim A; Barnett A
Menopause Int; 2008 Jun; 14(2):57-62. PubMed ID: 18519266
[TBL] [Abstract][Full Text] [Related]
20. Antiobesity drugs in the management of type 2 diabetes: A shift in thinking?
Burguera B; Ali KF; Brito JP
Cleve Clin J Med; 2017 Jul; 84(7 Suppl 1):S39-S46. PubMed ID: 28708481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
